Swiss National Bank - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 109 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,011,113
-8.0%
71,700
-5.4%
0.00%0.0%
Q2 2023$5,446,988
+25.6%
75,800
+7.8%
0.00%
+33.3%
Q1 2023$4,336,104
-23.0%
70,300
-3.7%
0.00%
-25.0%
Q4 2022$5,630,490
+82.3%
73,000
+5.5%
0.00%
+100.0%
Q3 2022$3,088,000
+21.1%
69,200
+3.9%
0.00%0.0%
Q2 2022$2,551,000
+6.2%
66,600
+14.8%
0.00%
+100.0%
Q1 2022$2,401,000
+18.8%
58,000
+8.4%
0.00%0.0%
Q4 2021$2,021,000
+14.6%
53,5000.0%0.00%0.0%
Q3 2021$1,763,000
-51.1%
53,5000.0%0.00%
-50.0%
Q2 2021$3,609,000
-0.4%
53,500
-16.4%
0.00%0.0%
Q1 2021$3,624,000
-29.6%
64,000
+1.3%
0.00%
-50.0%
Q4 2020$5,149,000
+14.7%
63,200
+0.3%
0.00%0.0%
Q3 2020$4,489,000
-11.9%
63,000
+1.8%
0.00%0.0%
Q2 2020$5,093,000
+85.0%
61,900
+32.3%
0.00%
+33.3%
Q1 2020$2,753,000
-42.2%
46,800
+1.5%
0.00%
-40.0%
Q4 2019$4,765,000
+443.9%
46,100
+6.5%
0.01%
+400.0%
Q3 2019$876,000
-21.4%
43,3000.0%0.00%0.0%
Q2 2019$1,115,00043,3000.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders